Quarterly report pursuant to sections 13 or 15(d)

RELATED-PARTY TRANSACTIONS (Details Narrative)

v2.3.0.11
RELATED-PARTY TRANSACTIONS (Details Narrative) (USD $)
1 Months Ended 12 Months Ended 45 Months Ended
Mar. 31, 2012
Feb. 28, 2011
Oct. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2008
Dec. 31, 2007
Oct. 23, 2011
Notes to Financial Statements                
Funding EMS received to purchase intellectual property rights             $ 59,000  
Funding Neurotrophics received to purchase intellectual property rights             100,000  
Funding CNS received to purchase intellectual property rights           100,000    
Notes issued pursuant to investments made into Neurotrophics           100,000    
Contingent liability obligations       222,230 287,462      
Notes issued pursuant to investments in favor of Neurotrophics, amount   222,083            
Notes issued pursuant to investments in favor of Neurotrophics, interest   2.00%            
Notes issued pursuant to investments in favor of Neurotrophics, maturity date   2015-03-05            
Notes issued pursuant to investments in favor of John and Gerald Commissiong, amount   59,319            
Notes issued pursuant to investments in favor of John and Gerald Commissiong, interest   2.00%            
Notes issued pursuant to investments in favor of John and Gerald Commissiong, maturity date   2015-12-30            
Royalty from Commercial Revenue     2.50%          
Royality from Commercial Revenue to John Commissiong     12.50%          
Royality from Commercial Revenue to Gerald Commissiong     12.50%          
Consulting services       200,000 200,000     479,166
Convertible Promissory Note converted, amount $ 21,000              
Convertible Promissory Note converted, shares 217,280